The Insides® Company is proud to provide the world's first chyme reinfusion medical registry.
The registry will provide a platform for clinicians using The Insides® System to record both the clinical and patient reported outcomes of chyme reinfusion. The registry will support the documentation of evidence around chyme reinfusion in intestinal failure patients and enhance the knowledge in this evolving treatment space. To further support these objectives clinicians can apply to use the data to in relevant publications.
The Insides® Clinical Data Registry has completed a Data Protection Impact Assessment (DPIA) with our external Data Protection Officer (DPO) to ensure the pseudo-anonomised data in the registry is secure.
The Health and Disability Ethics Committee has reviewed the registry for us in NZ to ensure that we are compliant with Ethics and Privacy Law.
The first sets of data have already been entered for patients treated in New Zealand
.png){kind=small}
.png){kind=small}
